| Literature DB >> 34646886 |
Chun-Jiang Tian1, Jian Lv1, Xiang-Feng Xu2.
Abstract
Over recent years, feature selection (FS) has gained more attention in intelligent diagnosis. This study is aimed at evaluating FS methods in a unified framework for mammographic breast cancer diagnosis. After FS methods generated rank lists according to feature importance, the framework added features incrementally as the input of random forest which performed as the classifier for breast lesion classification. In this study, 10 FS methods were evaluated and the digital database for screening mammography (1104 benign and 980 malignant lesions) was analyzed. The classification performance was quantified with the area under the curve (AUC), and accuracy, sensitivity, and specificity were also considered. Experimental results suggested that both infinite latent FS method (AUC, 0.866 ± 0.028) and RELIEFF (AUC, 0.855 ± 0.020) achieved good prediction (AUC ≥ 0.85) when 6 features were used, followed by correlation-based FS method (AUC, 0.867 ± 0.023) using 7 features and WILCOXON (AUC, 0.887 ± 0.019) using 8 features. The reliability of the diagnosis models was also verified, indicating that correlation-based FS method was generally superior over other methods. Identification of discriminative features among high-throughput ones remains an unavoidable challenge in intelligent diagnosis, and extra efforts should be made toward accurate and efficient feature selection.Entities:
Mesh:
Year: 2021 PMID: 34646886 PMCID: PMC8505067 DOI: 10.1155/2021/6079163
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Feature selection methods.
| ID | Acronym | Class | Learning strategy |
|---|---|---|---|
| A | CFS | Filter | Unsupervised |
| B | ECFS | Filter | Supervised |
| C | ILFS | Filter | Supervised |
| D | LAPLACIAN | Filter | Unsupervised |
| E | LASSO | Embedded | Supervised |
| F | LLCFS | Filter | Unsupervised |
| G | RELIEFF | Filter | Supervised |
| H | ROC | Filter | Unsupervised |
| I | UFSOL | Wrapper | Unsupervised |
| J | WILCOXON | Filter | Unsupervised |
Figure 1The proposed unified framework. It includes feature ranking, incremental feature selection, RF-based lesion classification, and performance evaluation, where features were precollected.
Figure 2AUC. A baseline (green) of AUC equal to 0.85 is added to the plots. In each plot, the red solid line indicates the test result, while the blue dashed line shows the retest result. Besides, error bars are added. Please note that the figure can be enlarged to perceive details.
Performance comparison. The metric values in bold come from the test study, while the values in the line below are from the retest study with corresponding features and model.
| No. | AUC | ACC | SEN | SPE | |
|---|---|---|---|---|---|
| CFS | 7 | 0.867 ± 0.023 | 0.733 ± 0.035 | 0.883 ± 0.018 | 0.793 ± 0.023 |
| 0.896 ± 0.020 | 0.724 ± 0.035 | 0.900 ± 0.018 | 0.806 ± 0.022 | ||
| ECFS | 9 | 0.887 ± 0.018 | 0.739 ± 0.028 | 0.894 ± 0.011 | 0.806 ± 0.014 |
| 0.926 ± 0.013 | 0.717 ± 0.034 | 0.915 ± 0.012 | 0.816 ± 0.017 | ||
| ILFS | 6 | 0.866 ± 0.028 | 0.678 ± 0.044 | 0.854 ± 0.030 | 0.763 ± 0.031 |
| 0.907 ± 0.025 | 0.665 ± 0.043 | 0.884 ± 0.027 | 0.779 ± 0.029 | ||
| LAPLACIAN | 12 | 0.863 ± 0.018 | 0.730 ± 0.030 | 0.880 ± 0.013 | 0.790 ± 0.016 |
| 0.891 ± 0.013 | 0.716 ± 0.028 | 0.893 ± 0.011 | 0.799 ± 0.014 | ||
| LASSO | 10 | 0.858 ± 0.020 | 0.685 ± 0.030 | 0.851 ± 0.013 | 0.763 ± 0.016 |
| 0.862 ± 0.019 | 0.692 ± 0.025 | 0.856 ± 0.011 | 0.772 ± 0.013 | ||
| LLCFS | 10 | 0.855 ± 0.020 | 0.735 ± 0.027 | 0.876 ± 0.009 | 0.789 ± 0.013 |
| 0.887 ± 0.014 | 0.714 ± 0.025 | 0.891 ± 0.009 | 0.796 ± 0.012 | ||
| RELIEFF | 6 | 0.855 ± 0.020 | 0.718 ± 0.026 | 0.868 ± 0.011 | 0.780 ± 0.013 |
| 0.880 ± 0.015 | 0.695 ± 0.037 | 0.876 ± 0.012 | 0.782 ± 0.019 | ||
| ROC | 10 | 0.878 ± 0.019 | 0.728 ± 0.029 | 0.885 ± 0.013 | 0.796 ± 0.016 |
| 0.919 ± 0.012 | 0.706 ± 0.035 | 0.908 ± 0.013 | 0.807 ± 0.018 | ||
| UFSOL | 10 | 0.858 ± 0.020 | 0.731 ± 0.028 | 0.877 ± 0.011 | 0.788 ± 0.013 |
| 0.889 ± 0.016 | 0.709 ± 0.029 | 0.892 ± 0.009 | 0.794 ± 0.014 | ||
| WILCOXON | 8 | 0.887 ± 0.019 | 0.726 ± 0.027 | 0.890 ± 0.013 | 0.799 ± 0.015 |
| 0.925 ± 0.013 | 0.707 ± 0.036 | 0.910 ± 0.013 | 0.810 ± 0.019 |
Performance comparison when using top two features for lesion representation.
| No. | AUC | ACC | SEN | SPE | |
|---|---|---|---|---|---|
| CFS | 2 | 0.711 ± 0.012 | 0.636 ± 0.013 | 0.714 ± 0.027 | 0.572 ± 0.030 |
| 0.715 ± 0.011 | 0.642 ± 0.012 | 0.718 ± 0.019 | 0.573 ± 0.026 | ||
| ECFS | 2 | 0.734 ± 0.013 | 0.660 ± 0.012 | 0.755 ± 0.026 | 0.581 ± 0.024 |
| 0.759 ± 0.010 | 0.677 ± 0.011 | 0.785 ± 0.018 | 0.579 ± 0.021 | ||
| ILFS | 2 | 0.678 ± 0.012 | 0.606 ± 0.012 | 0.698 ± 0.023 | 0.530 ± 0.026 |
| 0.724 ± 0.011 | 0.635 ± 0.011 | 0.752 ± 0.016 | 0.529 ± 0.025 | ||
| LAPLACIAN | 2 | 0.649 ± 0.014 | 0.603 ± 0.012 | 0.738 ± 0.025 | 0.492 ± 0.024 |
| 0.626 ± 0.014 | 0.590 ± 0.011 | 0.737 ± 0.023 | 0.458 ± 0.020 | ||
| LASSO | 2 | 0.557 ± 0.014 | 0.526 ± 0.013 | 0.651 ± 0.025 | 0.422 ± 0.028 |
| 0.552 ± 0.010 | 0.525 ± 0.010 | 0.653 ± 0.023 | 0.410 ± 0.023 | ||
| LLCFS | 2 | 0.517 ± 0.013 | 0.499 ± 0.013 | 0.645 ± 0.028 | 0.379 ± 0.024 |
| 0.507 ± 0.012 | 0.498 ± 0.011 | 0.648 ± 0.025 | 0.363 ± 0.025 | ||
| RELIEFF | 2 | 0.611 ± 0.013 | 0.568 ± 0.014 | 0.689 ± 0.022 | 0.486 ± 0.028 |
| 0.604 ± 0.073 | 0.574 ± 0.066 | 0.668 ± 0.021 | 0.490 ± 0.129 | ||
| ROC | 2 | 0.632 ± 0.013 | 0.582 ± 0.013 | 0.694 ± 0.025 | 0.491 ± 0.027 |
| 0.616 ± 0.011 | 0.571 ± 0.011 | 0.716 ± 0.021 | 0.440 ± 0.034 | ||
| UFSOL | 2 | 0.543 ± 0.015 | 0.514 ± 0.012 | 0.654 ± 0.027 | 0.399 ± 0.021 |
| 0.527 ± 0.013 | 0.513 ± 0.011 | 0.652 ± 0.024 | 0.388 ± 0.023 | ||
| WILCOXON |
| 0.605 ± 0.015 | 0.563 ± 0.015 | 0.686 ± 0.024 | 0.461 ± 0.028 |
| 0.629 ± 0.075 | 0.587 ± 0.069 | 0.679 ± 0.020 | 0.505 ± 0.133 |
Feature selection results. The top-most important features that achieve AUC larger than 0.85 are in bold to each FS method.
| The most to the least important features | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CFS |
|
|
|
|
|
|
| 6 | 2 | 8 | 13 | 17 | 10 | 9 | 1 | 4 | 12 | 18 |
| ECFS |
|
|
|
|
|
|
|
|
| 3 | 14 | 6 | 13 | 15 | 7 | 11 | 5 | 18 |
| ILFS |
|
|
|
|
|
| 13 | 1 | 4 | 2 | 10 | 6 | 9 | 7 | 16 | 12 | 8 | 17 |
| LAPLACIAN |
|
|
|
|
|
|
|
|
|
|
|
| 15 | 10 | 13 | 14 | 17 | 12 |
|
|
|
|
|
|
|
|
|
|
|
| 9 | 5 | 3 | 7 | 11 | 14 | 10 | 12 |
| LLCFS |
|
|
|
|
|
|
|
|
|
| 18 | 6 | 15 | 10 | 14 | 13 | 17 | 12 |
| RELIEFF |
|
|
|
|
|
| 4 | 12 | 3 | 9 | 13 | 17 | 16 | 6 | 15 | 5 | 1 | 2 |
| ROC |
|
|
|
|
|
|
|
|
|
| 11 | 15 | 6 | 14 | 13 | 18 | 7 | 5 |
| UFSOL |
|
|
|
|
|
|
|
|
|
| 18 | 6 | 17 | 12 | 15 | 10 | 13 | 14 |
| WILCOXON |
|
|
|
|
|
|
|
| 14 | 2 | 1 | 13 | 3 | 18 | 7 | 11 | 15 | 5 |